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Kaposi’s sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8, HHV-8) belongs to the g-herpesvirus subfamily.
The KSHV ORF57 gene is thought to be a homolog of posttranscriptional regulators that are conserved in the herpesvirus family and are
essential for replication. We generated specific monoclonal antibodies (mAbs) against the ORF57 protein that detected the 51-kDa protein
expressed in the nucleus of KSHV-infected cells. We also found that the ORF57 protein interacted with poly(rC)-binding protein 1 (PCBP1),
a cellular RNA-binding, posttranscriptional regulator. ORF57’s interaction with PCBP1 enhanced the activity of not only poliovirus internal
ribosome-entry site (IRES)-dependent translation but also X-linked inhibitor of apoptosis (XIAP) and KSHV vFLIP IRES. Actually, when
ORF57 expression was induced by the expression of replication and transcription activator (RTA) in KSHV-infected cells, the expression of
XIAP was enhanced. These results suggest that ORF57 binds to PCBP1 as a functional partner for posttranscriptional regulation and is
involved in the regulation of the expression of both cellular and viral genes through IRESs.
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Kaposi’s sarcoma-associated herpesvirus (KSHV), which
is also known as human herpesvirus 8 (HHV-8), was
discovered in Kaposi’s sarcoma (KS) (Chang et al., 1994),
the most common AIDS-related malignancy. KSHV DNA is
found in most cases of both AIDS-related and classical KS
lesions (Schulz, 1998). Moreover, KSHV is also involved in
the pathogenesis of multicentric Castleman’s disease (MCD)
(Soulier et al., 1995) and primary effusion lymphoma (PEL)
(Cesarman et al., 1995a), which suggests that KSHV could
be an oncogenic DNA virus. Based on sequence analyses
(Russo et al., 1996), KSHV is classified as a new member of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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herpesvirus saimiri (HVS), murine g-herpesvirus 68
(MHV68), and Epstein–Barr virus (EBV), all of which
are also thought to be oncogenic viruses (Efstathiou et al.,
1990; Moore et al., 1996). Several KSHV-infected cell lines
have been established from PELs (Arvanitakis et al., 1996;
Cesarman et al., 1995b; Gaidano et al., 1996), and, like the
other g-herpesviruses (zur Hausen et al., 1978), KSHV can
be induced to undergo lytic replication by chemical agents
such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and n-
butyrate in these cell lines (Miller et al., 1997; Yu et al.,
1999).
Immediate-early (IE) genes have critical roles in lytic
replication and reactivation. IE genes, most of which encode
regulatory proteins that alter the expression of viral and
cellular genes, are the first class of viral genes expressed
after primary infection, lytic replication, and reactivation.
The replication and transcription activator (RTA) of KSHV
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other lytic genes (Lukac et al., 1999; Sun et al., 1999), and
plays a critical role in inducing the viral lytic cycle in
KSHV-infected cell lines (Gradoville et al., 2000; Nishimura
et al., 2001). RTA induces the expression of several lytic
genes, including ORF57 (Chen et al., 2000; Song et al.,
2001; Sun et al., 1998; Ueda et al., 2002).
KSHV ORF57 is homologous to posttranscriptional
regulators such as herpes simplex virus (HSV) ICP27,
human cytomegalovirus (CMV) UL69, varicella-zoster vi-
rus (VZV) ORF4, EBV Mta, and HVS ORF57 (Buisson et
al., 1999; Defechereux et al., 1997; Rice and Knipe, 1990;
Whitehouse et al., 1998; Winkler et al., 1994). Among them,
HSV ICP27 has been studied most intensively, and the
results of these studies have highlighted the multifunctional
nature of this protein. For example, it binds RNA, enhances
RNA 3’ processing, inhibits host cell splicing, and facili-
tates the nuclear export of HSV transcripts (Brown et al.,
1995; Hardy and Sandri-Goldin, 1994; Phelan et al., 1996).
Recent analyses have shown that KSHV ORF57 enhances
the expression of some genes in a posttranscriptional man-
ner and has some features similar to ICP27 (Bello et al.,
1999; Gupta et al., 2000; Kirshner et al., 2000).
Here we generated anti-ORF57 mouse monoclonal anti-
bodies (mAbs) and used them to reveal the ORF57 expres-
sion profile and subcellular localization in KSHV-infected
PEL cells after induction of lytic replication. Furthermore,
using yeast two-hybrid screening, we found that ORF57
bound to the poly(rC)-binding protein 1 (PCBP1; also called
hnRNP-E1 or aCP1) as a functional partner. PCBP1 is an
RNA-binding protein that was originally identified as part
of the a-globin mRNP complex associated with a-globin
mRNA stability (Kiledjian et al., 1995). Recent studies
indicate that an association between PCBP1 and several
cellular and viral RNAs is important for the RNAs’ post-
transcriptional regulation, either by stabilizing or directly
influencing their translational activity (Ostareck-Lederer et
al., 1998). Our results suggest that ORF57 interacts with
PCBP1 to function as a posttranscriptional regulator through
the internal ribosome-entry site (IRES).Results
ORF57 protein expression is strongly induced by TPA
treatment in the KSHV-infected PEL cell line
We generated mouse monoclonal antibodies (mAbs)
against the ORF57 protein. mAb K1 reacted specifically
with the ORF57 protein expressed in transfected 293 cells
(data not shown) and in TPA-induced KSHV-infected PEL
cells, as assessed by both immunofluorescence assays (IFA)
(Figs. 1A and B) and Western blotting (Fig. 1C). We
examined the time course of ORF57 protein expression by
IFA in TPA-induced BC-3 cells. Less than 1% of uninduced
BC-3 cells expressed the ORF57 protein (Fig. 1A; a).ORF57 expression in BC-3 cells began to increase 4 h after
TPA induction and reached a maximum (>50%) 24–48
h after induction (Fig. 1A; b–f). In contrast, the K9 (vIRF)
protein, which is encoded by an early gene, was first
detected 12 h after the induction, and the maximum number
of positive cells was <30% around 48 h after induction, by
IFA (data not shown).
These results indicate that the monoclonal antibody
against ORF57 recognized the expressed ORF57 protein
specifically and that the expression of ORF57 was strongly
induced in the lytic cycle as described elsewhere (Lukac et
al., 1999).
Subcellular localization and molecular weight of the ORF57
protein
To identify the subcellular localization of the ORF57
protein, TPA-induced BC-3 cells were double labeled with
mAb K1 and DAPI and observed using confocal fluorescent
microscopy. As shown in Fig. 1B, the ORF57 protein was
localized predominantly to the nucleus. The nuclear fluo-
rescent pattern of ORF57 resembled that of HSV ICP27
(Phelan et al., 1993), which is considered to be a homologue
of KSHV ORF57.
The mobility of the ORF57 protein on sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
was analyzed by Western blotting. mAb K1 specifically
recognized the ORF57 protein in whole-cell extract that was
enriched with nuclear protein extract from TPA-induced
BC-3 cells with a slight nonspecific reaction to some
proteins in the nuclear extract from TPA-induced and
-uninduced cells (Fig. 1C). The estimated molecular weight
of the ORF57 protein on SDS-PAGE was about 51 kDa,
almost the same as the predicted molecular weight.
ORF57 interacts with an RNA-binding protein, PCBP1
To identify cellular proteins that interact with the ORF57
protein and elucidate its functional relationships, we carried
out a yeast two-hybrid screen. The full-length ORF57 cDNA
was fused to the GAL4 DNA-binding domain and used to
screen a cDNA library from EBV-transformed B cells.
We obtained 11 positive clones by screening approxi-
mately one million independent clones. Sequence analysis
and homology search with BLAST (NCBI) showed that
these clones included parts of the poly(rC)-binding protein 1
(PCBP1), apoptosis antagonizing transcription factor
(AATF), nuclear matrix protein p84, and katanin p80
subunit B1. PCBP1 was originally identified as a constituent
of the a-globin mRNP complex that is involved in a-globin
mRNA stability (Kiledjian et al., 1995). The PCBP1 protein
has three KH domains that enable it to interact with a
pyrimidine-rich binding sequence in target RNAs and func-
tions as an RNA-binding protein implicated in the control of
mRNA turnover and translation (Ostareck-Lederer et al.,
1998). Because HSV ICP27, which is thought to be a
Fig. 1. Expression profile of ORF57 in BC-3 cells. (A) Time course of ORF57 expression in BC-3 cells. The cells were fixed at the indicated time after TPA
induction and labeled with an anti-ORF57 mouse monoclonal antibody followed by FITC-conjugated anti-mouse IgG antibodies. Original magnification:
100. (B) IFA of ORF57 protein. The cells were fixed after a 24-h exposure to TPA and stained as described in Materials and methods. (Left) The ORF57
staining pattern, (middle) the DAPI staining pattern, and (right) the merged image. Original magnification: 400. (C) Western blotting analysis of ORF57
protein. Whole-cell and nuclear extracts from BC-3 and BJAB cells untreated () or treated (+) with TPA for 24 h were prepared, fractionated on SDS-PAGE,
transferred to a polyvinylidene difluoride membrane, and incubated with the anti-ORF57 monoclonal antibody. Molecular mass markers are shown on the left.
The arrow indicates the ORF57 protein.
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binding protein, hnRNP K (Wadd et al., 1999), which also
has KH-domains, we investigated the interaction between
ORF57 and PCBP1 in detail.
The PCBP1 gene is expressed with a wide tissue distri-
bution (Makeyev et al., 1999), and we detected PCBP1RNA in KSHV-infected PEL cells, as well (Fig. 2A). To
investigate whether ORF57–PCBP1 complexes are formed
in vivo, co-immunoprecipitation was performed. For this
experiment, full-length ORF57 and PCBP1 cDNAs, which
were cloned by RT-PCR, were fused to the HA-tag and
FLAG-tag, respectively. Nuclear extracts prepared from 293
Fig. 2. (A) Expression of the PCBP1 gene in 293 cells and KSHV-infected
PEL cells. Total RNA was extracted from each cell, and, after the first-
strand cDNA synthesis protocol with (+) or without () reverse
transcriptase was performed, a specific fragment encoding PCBP1 was
amplified by PCR using the primers PCBP1p1-Eco and PCBP1rp1-Eco.
The arrow indicates the PCBP1 mRNA. (B) Detection of ORF57–PCBP1
complexes by co-immunoprecipitation. Nuclear extracts from 293 cells
transfected with ORF57 or PCBP1 expression vector (+) or each control
vector () were incubated with rabbit polyclonal anti-HA antibodies. The
protein–antibody complexes were isolated and analyzed by Western
blotting with an anti-FLAG or anti-ORF57 antibody as described in
Materials and methods. Western blotting of the input extracts for this co-
immunoprecipitation is also shown. The positions of the FLAG-tagged
PCBP1 and HA-tagged ORF57 are indicated by arrows.
Fig. 3. Co-localization of PCBP1 and ORF57. 293 cells were transfected with pFL
and labeled with anti-FLAG mouse monoclonal antibodies (A and D) and anti-H
show merged images.
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for ORF57 and PCBP1 were incubated with anti-HA rabbit
polyclonal antibodies, and the precipitated proteins were
subjected to Western blotting analysis for the FLAG-tag.
Fig. 2B shows that the PCBP1 protein co-precipitated with
the ORF57 protein in nuclear extract from cells expressing
both proteins (lane 3), but not from cells expressing only
one of them (lanes 1 and 2).
In addition, we tested the co-localization of ORF57
and PCBP1 in vivo by IFA. Although the diverse
functions of PCBP1 suggest that it acts both in the
nucleus and the cytoplasm, a transfection study of
pFLAG-PCBP1 in 293 cells showed that it was expressed
predominantly in the nucleus (Fig. 3A), and this finding
was consistent with the recent report that PCBP1 has one
nuclear localization signal (NLS) (Chkheidze and Lieb-
haber, 2003). Co-localization of the ORF57 and PCBP1
proteins in the nucleus was verified in 293 cells co-
transfected with expression vectors for these two proteins
(Figs. 3D–F).
Taken together, results from the yeast two-hybrid screen,
co-immunoprecipitation, and co-transfection study with IFA
indicated that the ORF57 protein and the cellular protein
PCBP1 interact both in vitro and in vivo.
Mapping of the interaction region of ORF57–PCBP1
binding
To define the region of ORF57 that is involved in the
interaction with PCBP1, we examined the ability of full-
length and truncated versions of ORF57 (Fig. 4A) to interact
with PCBP1. All constructs were fused to the HA-tag at the
N-terminus and expressed in 293 cells. All the ORF57
deletion mutants were expressed in the nucleus (data notAG-PCBP1 only (A–C) or pFLAG-PCBP1 and pCMV-HA-ORF57 (D–F),
A rabbit polyclonal antibodies (B and E). The right-hand panels (C and F)
Fig. 4. Mapping of the region of ORF57 that interacts with PCBP1. (A) A
schematic diagram of the ORF57 protein expressed as HA-tagged fusion
proteins. The ability to bind to PCBP1 is summarized on the right. The
PCBP1-binding site that was predicted from the results in B is indicated.
(B) The binding of the ORF57 mutants to PCBP1. Whole-cell lysate from
293 cells expressing full-length ORF57, ORF57DC205, ORF57DC104,
ORF57DN179, or ORF57 (179–205) was incubated with GST-PCBP1DN
protein immobilized on glutathione-Sepharose beads. Each lysate (L) and
eluted glutathione-binding fraction (E) was analyzed by Western blotting
using anti-HA rabbit polyclonal antibodies.
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nuclear localization signals. Cell lysates were made from
293 cells expressing the full-length or truncated ORF57
protein and incubated with control GST protein or GST-
PCBP1DN protein, the region of PCBP1 that interacted with
ORF57 in a yeast two-hybrid screen fused with GST. While
none of the HA-tagged ORF57 constructs bound to control
GST protein (data not shown), an ORF57DC205 construct
containing aa 1–205 bound to PCBP1, as did an N-terminal
deletion construct, ORF57DN179 (aa 179–456) (Fig. 4B).
In contrast, a construct containing aa 1–104, ORF57DC104,
did not, and ORF57 (179–205) containing aa 179–205, the
over lapping region between ORF57DC205 and
ORF57DN179, bound to PCBP1. These results indicate that
aa 179–205 of ORF57 contained the PCBP1-binding re-
gion. We searched for a protein interaction motif with the
Prosite profile, ProDom profile, and PRINT profile through
MotifFinder, but could not find a typical motif in this
region.
A similar approach was used to map the ORF57-binding
site in PCBP1 protein. A series of fragments of PCBP1 were
expressed as GST fusion proteins (Figs. 5A and B), and
their ability to bind to full-length ORF57 in the nuclear
extract from KSHV-infected cells was determined. The
series of deleted versions of PCBP1 were well expressedin Escherichia coli and detected in the eluted fraction. In
this experiment, ORF57 bound to PCBP1DC169 (aa 48–
169) and PCBP1DC96 (aa 48–96), but not PCBP1DN97 (aa
97–356) (Fig. 5C), indicating that the ORF57-binding site
existed in aa 48–96 of PCBP1.
The ORF57–PCBP1 interaction modulates the function of
PCBP1
PCBP1 is involved in a remarkable array of biological
processes. This protein is linked to a-globin mRNA stabi-
lization (Kiledjian et al., 1995), and to the translational
silencing of 15-lipoxygenase (Ostareck et al., 1997) and
papillomavirus L2 (Collier et al., 1998). It also enhances the
translation activity of the poliovirus internal ribosome-entry
site (IRES) (Gamarnik and Andino, 1997). Therefore, we
investigated the effect of ORF57 on the poliovirus IRES in
this experiment.
To evaluate the translational regulation of the poliovirus
IRES by ORF57, we constructed a bicistronic reporter
plasmid (pCMVh-IRES-Luc) that contained a h-galactosi-
dase gene driven by the CMV IE promoter and a luciferase
gene driven by the poliovirus IRES inserted between the
h-galactosidase gene and the poly(A) signal (Fig. 6A). We
could assess IRES-dependent translation of the luciferase
gene in this plasmid by normalizing the luciferase activity
to the h-galactosidase activity. As shown in the inset of
Fig. 6B, this bicistronic plasmid expressed a substantial
amount of luciferase, but the control plasmid, which did not
contain the IRES sequence (pCMVh-con-Luc), did not.
This experiment confirmed that the inserted IRES was
functional and that expression of the luciferase gene was
substantially dependent on the IRES. We also confirmed
that expression of the h-galactosidase and luciferase genes
from pCMVh-con-Luc was not affected by the introduction
of either the PCBP1 or ORF57 expression vector (data not
shown).
When 293 cells were co-transfected with the PCBP1
expression vector and the reporter plasmid, IRES-depen-
dent translation increased by about 4-fold (compare bar 4
to 1, Fig. 6B), suggesting that activation of the poliovirus
IRES by the overexpression of PCBP1 could be detected in
this assay. The co-expression of ORF57 and PCBP1 led to
an additional enhancement of about 8-fold (compare bar 5
to 4, Fig. 6B). In contrast, when the cells were transfected
with ORF57DC104, which could not bind to PCBP1 (see
Fig. 4B), this additional enhancement of translation was
not observed (compare bar 6 to 4, Fig. 6B). These data
suggest that the interaction between ORF57 and PCBP1 is
involved in the IRES-mediated translation activity. Further-
more, the ORF57 protein alone also activated the IRES-
dependent translation (bar 2, Fig. 6B), probably because
endogenous PCBP1 was expressed in 293 cells (see Fig.
2A). ORF57 overexpression did not activate the expression
of transfected PCBP1 (compare lane 6 to 5, Fig. 2B, upper
panel).
Fig. 5. Mapping of the region of PCBP1 that interacts with ORF57. (A) A schematic diagram of the PCBP1 protein expressed as GST-tagged fusion proteins.
The ability to bind to ORF57 is summarized on the right. The ORF57-binding site that was predicted from the result of C is indicated. The positions of the three
KH domains are also indicated. (B and C) The binding of the PCBP1 mutants to ORF57. Nuclear extract from BC-3 cells was incubated with GST-PCBP1DN,
GST-PCBP1DC279, GST-PCBP1DC169, GST-PCBP1DC96, or GST-PCBP1DN97 protein immobilized on glutathione-Sepharose beads. Each unbound flow-
through (T), lysate (L), or eluted glutathione-binding fraction (E) was analyzed by Western blotting using an anti-GST mouse monoclonal antibody (B), or anti-
ORF57 mouse monoclonal antibody (C). Asterisks and an arrow indicate the position of each truncated PCBP1 protein fused to GST and ORF57, respectively.
K. Nishimura et al. / Virology 325 (2004) 364–378 369To confirm the effect of ORF57 and PCBP1 expres-
sion on transcription, the RNA levels of the luciferase and
the control h-galactosidase genes were estimated (Fig.
6C). ORF57 expression did not affect the luciferase RNA
level generally compared to that obtained with PCBP1
expression (compare bar 1 to 2, Fig. 6C). Co-overexpres-
sion of PCBP1 and ORF57 also doubled the level of
luciferase RNA (compare bar 5 to 4, Fig. 6C), but this
increase was much less than the increased luciferase
protein level (compare bar 5 to 4, Fig. 6B). Thus,
ORF57 overexpression either with or without PCBP1
overexpression did not necessarily activate the luciferase
gene expression at the RNA level in this assay, although
it is not clear why the expression of these proteins
decreased the RNA level of the luciferase gene, and these
data suggest that ORF57 enhances translation rather than
transcription.The interaction between ORF57 and PCBP1 controls gene
expression through the IRES
It has been noted that not only poliovirus but also some
eukaryotic mRNAs are translated by IRES-mediated mech-
anisms (Holcik et al., 2000). Furthermore, the KSHV
vCyclin-vFLIP bicistronic mRNA also possesses an IRES
element by which the translation of vFLIP is initiated
(Bieleski and Talbot, 2001). Here, we tested whether
ORF57 influenced the IRES-dependent expression of c-
myc (Nanbru et al., 1997), NF-nB repressing factor (NRF)
(Oumard et al., 2000), X-linked inhibitor of apoptosis
(XIAP) (Holcik et al., 1999), and vFLIP. Each IRES
sequence was cloned and inserted into the h-galactosi-
dase/luciferase bicistronic plasmid in place of the poliovi-
rus IRES, and the resultant plasmids were subjected to the
IRES-dependent expression assay, as described above. As
K. Nishimura et al. / Virology 325 (2004) 364–378370shown in Fig. 6D, the translation activity of the XIAP
IRES was markedly activated by the co-expression of
ORF57 and PCBP1, whereas the c-myc IRES was not
influenced by ORF57 or PCBP1. ORF57 also enhanced
NRF expression, but the overexpression of PCBP1 seemed
instead to suppress the NRF IRES activity. In the case of
the vFLIP IRES, translation activity was moderately en-
hanced by ORF57, but the overexpression of PCBP1 hadlittle influence, suggesting that PCBP1 might not be
involved in the IRES-mediated translation of vFLIP. Taken
together, these results suggest that ORF57 in cooperation
with PCBP1 effectively activates XIAP IRES-dependent
translation. Some other factors may be cooperatively
involved in the ORF57-mediated NRF and vFLIP IRES
activities, although whether these factors include PCBP1
remains to be discovered.
K. Nishimura et al. / Virology 325 (2004) 364–378 371To confirm the effect of ORF57 on the translation of
XIAP, we examined XIAP expression in ORF57-expressing
cells. First, the change of XIAP expression in 293 cells
transfected with or without the ORF57 expression vector
was analyzed by Western blotting. However, the apparent
increase in XIAP protein by ORF57 expression was not
observed, partly because of a high baseline expression of
XIAP in 293 cells (data not shown) and the difficulty in
observing effects on XIAP expression in a transient trans-
fection assay. Neither transfection of KSHV-infected cells
with an ORF57 expression vector nor the induction of
ORF57 expression by TPA seemed to be suitable for this
analysis because of a low transfection efficiency and wide
inducibility of TPA, respectively. Thus, we next analyzed
XIAP expression in KSHV-infected cells in which the
expression of KSHV RTA was inducible. Recently, we
isolated a cloned cell line from KSHV-positive BCBL-1
cells and another from KSHV-negative BJAB cells that
stably express KSHV RTA under the control of an inducible
promoter of the tetracycline-based Tet-Off expression sys-
tem (BCBL-1/off + RTA and BJAB/off + RTA, respective-
ly) (Nishimura et al., 2003). In these cell lines, tetracycline
removal induced the synthesis of RTA (Fig. 7A), followed
by a remarkable induction of ORF57 expression in cells
24–48 h after the induction of RTA in BCBL-1/off + RTA
(Fig. 7B). As shown in Fig. 7C, the induction of RTA
expression in BCBL-1/off + RTA, which was related to the
induction of ORF57 expression, resulted in an increase in
XIAP expression by more than 6-fold 72 h postinduction,
and in contrast, RTA expression caused no change in XIAP
expression in RTA-inducible BJAB cells, which did not
have the ORF57 gene. Furthermore, there was little change
in the RNA level of XIAP up to 72 h after RTA induction in
BCBL-1/off + RTA, although the RTA and the ORF57
transcription levels reached a maximum 24 h after induction
(Fig. 7D), suggesting that the increase in XIAP protein was
not caused by an increase in its transcription level. Thus,
these results suggested that ORF57 might induce an increase
in XIAP expression at the protein level in KSHV-infected
cells, in agreement with the activation of XIAP IRES
responsiveness to ORF57, although the involvement of
other factors cannot be excluded completely.Fig. 6. Effect of ORF57 and PCBP1 on IRES-dependent gene expression. (A) Str
detect IRES activity. BglII restriction enzyme sites upstream and downstream of
enhances the IRES activity. 293 cells were transiently co-transfected with a repo
parental vector () as indicated. Thirty-six hours after transfection, the cell ext
determined. Relative luciferase activity was calculated by normalizing the luciferas
cells transfected with pCMVh-IRES-Luc and two parental vectors (pFLAG-CMV
shown. Inset box: 293 cells transfected with pCMVh-Con-Luc () or pCMVh-IRE
in the lysate were measured. (C) RNA level of the luciferase gene. The same sets
transfection. Approximately 10 Ag of total RNA from each combination was revers
RNA level of the luciferase gene, transfection efficiency was normalized to the h
twice and the mean and standard deviation was calculated. (D) ORF57 activate
pCMVh-IRES-Luc was replaced by the IRES sequences of the indicated genes at th
assay for IRES-dependent translation. Cell culture and measurement of h-galacto
average with standard deviation (SD) of three independent transfections.Discussion
The generation of anti-ORF57 mouse monoclonal anti-
bodies has enabled us to elucidate the expression profile of
ORF57 in KSHV-infected PEL cells. Strong induction in the
lytic replication phase and the nuclear localization of
ORF57 resembled that of EBV Mta, which plays an
important role in posttranscriptional regulation, as does
another homologue, HSV ICP27, and all these proteins
are reported to shuttle between the nucleus and the cyto-
plasm (Buisson et al., 1999; Cho et al., 1985). These
similarities suggest that KSHV ORF57 could also act as a
posttranscriptional regulator. In this respect, previous
reports showed that ORF57 activates gene expression in a
posttranscriptional manner (Gupta et al., 2000; Kirshner et
al., 2000). However, the mechanism of posttranscriptional
regulation by ORF57 has been unclear.
Here, we carried out a yeast two-hybrid screen to
elucidate the function of ORF57 by identifying cellular
functional partners that interact with the ORF57 protein.
One of the clones obtained in this screen was a cellular
RNA-binding protein, PCBP1. We confirmed the interaction
between ORF57 and PCBP1 by immunoprecipitation fol-
lowed by Western blotting analysis, immunostaining, GST
pull-down assay, and by testing their ability to enhance
translation mediated by the poliovirus IRES. Although most
of the translational phase of protein synthesis takes place in
the cytoplasm, ORF57 and PCBP1 were co-localized in the
nucleus of cells co-transfected with expression vectors for
both proteins. It has been reported that transfected hnRNP K
is expressed exclusively in the nucleus, although it shuttles
between the nucleus and cytoplasm (Michael et al., 1997),
suggesting that PCBP1 may have the same property. More-
over, ORF57 also shuttles between the nucleus and cyto-
plasm (Bello et al., 1999). Taken together, these reports and
our data suggest that ORF57 might shuttle between the
nucleus and the cytoplasm with PCBP1 and that they might
act together to control gene expressions in a posttranscrip-
tional manner.
The PCBP1 protein belongs to a family of poly(rC)-
binding proteins (PCBPs) that can be divided into two
groups, the hnRNPs K/J and the aCPs (PCBP1–4). Amongucture of the bicistronic h-galactosidase/luciferase reporter plasmid used to
the poliovirus IRES element are indicated. (B) ORF57–PCBP1 interaction
rter gene construct (pCMVh-IRES-Luc) and effector plasmids (+) or each
racts were prepared and the h-galactosidase and luciferase activities were
e activity to the h-galactosidase activity. The mean luciferase activity of the
-2 and pCMV-HA) was set at 1, and the mean fold activity for each case is
S-Luc (IRES) were lysed 36 h after transfection, and the luciferase activities
of transfection were performed and the total RNA was extracted 36 h post-
e-transcribed and subjected to real-time PCR analysis. For calculation of the
-galactosidase RNA copy number. Triplicate transfections were performed
s translation dependent on other IRESs. The poliovirus IRES sequence in
e BglII sites, and the resultant bicistronic reporter plasmids were used in the
sidase and luciferase activities were done as in (B). The bars represent the
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jian et al., 1995) and have many similar functions, including
RNA stabilization and translational silencing or activation
(Makeyev and Liebhaber, 2002). Moreover, the binding
region of PCBP1 to ORF57 investigated in Fig. 5 has very
high identity (97%) to the homologous region of PCBP2,
in which only one amino acid is different. These datasuggest that ORF57 might also be able to bind to PCBP2
and be involved in PCBP2-mediated IRES functioning.
IRES elements have been found in several cellular
mRNAs so far: growth factors (FGF-2, c-sis, and VEGF),
oncogenes (c-myc and ODC), regulators of apoptosis (Apaf-
1, DAP5, and XIAP), and a transcription factor (NRF)
(Holcik et al., 2000). It is speculated that the presence of
K. Nishimura et al. / Virology 325 (2004) 364–378 373an IRES within a cellular mRNA allows enhanced or
continued expression under conditions where cap-dependent
translation is shut off or compromised, such as during heat
shock, developmental apoptosis, or viral infection (Sachs et
al., 1997). However, these IRES elements have no obvious
sequence similarity to each other or to the poliovirus IRES
sequence, and very few control mechanisms of IRES-
directed translation have been described. For example, the
polypyrimidine tract protein (PTB) binds to the Apaf-1
IRES, the La autoantigen binds to the BiP and XIAP IRESs,
and the heterogeneous nuclear ribonucleoproteins C1 and
C2 (hnRNPC1 and-C2) also bind to XIAP IRES, and the
binding of these molecules to the IRESs stimulates transla-
tion (Holcik and Korneluk, 2000; Holcik et al., 2003; Kim et
al., 2001; Mitchell et al., 2001). Although it is still uncertain
whether the effect of ORF57 on XIAP IRES activation
requires the La autoantigen, hnRNPC1, or hnRNPC2, our
data suggest that the interaction of ORF57 with the ubiqui-
tous PCBP1 is likely to be involved in the XIAP IRES-
dependent translation, and ORF57 may be involved in the
expression of the anti-apoptosis factor. This process may
lead to the inhibition of apoptosis in KSHV-infected cells
during lytic replication and/or reactivation.
In fact, when ORF57 expression was induced by the
expression of RTA in KSHV-infected cells, the expression
of XIAP was enhanced. In this case, it is possible that some
other factor, not ORF57, induced by RTA may increase
XIAP expression. However, these phenomena were not
observed in RTA-expressing non-KSHV-infected cells
(BJAB/off + RTA), thus it is unlikely that the induction
of cellular factors by RTA was involved in this enhance-
ment, at least. Recently, we reported that the induction of
RTA expression led to cell death by apoptosis in non-
KSHV-infected cells (BJAB/off + RTA), but not in KSHV-
infected cells (BCBL-1/off + RTA) (Nishimura et al., 2003).
These results support the idea that the induction of XIAP
expression by ORF57 may inhibit apoptosis in KSHV-
infected cells during reactivation. Pickering et al. (2003)
recently reported that PCBP1 increased the activity of
BAG-1, an anti-apoptotic gene whose translation is medi-
ated by IRES. The interaction between ORF57 and PCBP1
may be involved in the induction of this anti-apoptotic
factor.Fig. 7. Increase in XIAP expression linked with the induction of ORF57. (A) RTA
extracts were obtained at different times postinduction (Tc[]) and analyzed by W
total protein (20 Ag) was loaded in each lane. The arrow indicates RTA protein. (B
RTA cells. Whole-cell extracts from BCBL-1/off + RTA cells and BJAB/off +
analyzed by Western blotting using the specific antibody against ORF57. The sam
of XIAP expression in RTA-induced BCBL-1/off + RTA cells. Whole-cell extracts
the postinduction time (Tc[]) shown and analyzed by Western blotting using spe
of total protein (5 Ag) was loaded in each lane. The band intensity was quantified
protein was normalized by calculating the intensity of XIAP expression relative
a-tubulin in uninduced cells (Tc[+]) was set at 1, and the fold value for each cas
expression was induced by the withdrawal of tetracycline (Tc) in BCBL-1/off + R
RNAwas reverse-transcribed and subjected to real-time PCR. Each RNA level wa
RNA level was measured in triplicate. The mean value and standard deviation w
determined by setting the value before induction at 1, respectively.The translation of KSHV vFLIP is reported to be
mediated by an IRES element (Bieleski and Talbot, 2001),
and we found that ORF57 also activated vFLIP’s transla-
tion. The induction of KSHV replication by TPA causes a
small increase in the expression of the vFLIP protein,
although vFLIP expression is mainly seen in the latent
phase (Low et al., 2001). These facts and our data open
the possibility that ORF57 may help maintain vFLIP ex-
pression during lytic replication or reactivation, which may
result in the inhibition of apoptosis, just as for XIAP.
PCBP1 has another function in posttranscriptional regu-
lation relating to the inhibition of the translation of papillo-
mavirus type 16 L2 mRNA (Collier et al., 1998). L2 mRNA
encodes a minor capsid protein and has cis-acting sequences
in its 3’ end that inhibit protein production without affecting
mRNA levels. PCBP1 protein specifically binds to this
region and silences the L2 mRNA. Because there is no
obvious sequence similarity between the PCBP1-binding
region of the poliovirus IRES and L2 mRNA, PCBP1 may
be involved in various kinds of RNA binding, and the
interaction of ORF57 with PCBP1 may regulate the trans-
lational activation or silencing of many KSHV and cellular
genes, in addition to vFLIP and XIAP.
Thus, we showed that ORF57 regulated gene expression
by interacting with IRES-binding proteins as a posttran-
scriptional regulator. Further study of the effect of the
ORF57–PCBP1 interaction on IRES-mediated translation
will lead to a better understanding of the functions of
PCBP1 and IRES as well as of KSHV ORF57.Materials and methods
Cell lines
The PEL-derived cell lines BCBL-1 and BC-3 were
grown in RPMI 1640 medium supplemented with 20%
heat-inactivated fetal bovine serum (FBS) at 37 jC in the
presence of 5% CO2. RTA-inducible cells (BCBL-1/off +
RTA and BJAB/off + RTA) were grown in RPMI 1640
medium supplemented with 20% heat-inactivated FBS, 0.8
mg/ml G418, 0.4 mg/ml hygromycin, and 0.1 Ag/ml tetra-
cycline (Nishimura et al., 2003). To induce expression ofexpression in BCBL-1/off + RTA and BJAB/off + RTA cells. Whole-cell
estern blotting using a specific antibody against RTA. The same amount of
) ORF57 expression in RTA-induced BCBL-1/off + RTA and BJAB/off +
RTA cells were prepared at the postinduction time (Tc[]) indicated and
e amount of total protein (10 Ag) was loaded in each lane. (C) Enhancement
from BCBL-1/off + RTA cells and BJAB/off + RTA cells were prepared at
cific antibodies against XIAP and a-tubulin, respectively. The same amount
using a GS-800 Calibrated Densitometer, and the relative amount of XIAP
to that of a-tubulin expression. The intensity of XIAP protein to that of
e is represented. (D) Transcription level of RTA, ORF57, and XIAP. RTA
TA, and total RNAwas extracted 24, 48, and 72 h later. About 10 Ag of the
s normalized to that of GAPDH. Experiments were performed twice and the
as calculated. The arbitrary fold values of RTA, ORF57, and XIAP were
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washed twice with phosphate-buffered saline (PBS), then
cultured in the medium with (uninduced) or without (in-
duced) 0.1 Ag/ml tetracycline. Lytic gene expression of
parental BCBL-1 cells was induced by treatment with 12-
O-tetradecanoylphorbol-13-acetate (TPA) at 25 ng/ml. 293
cells were maintained in Dulbecco’s modified Eagle medi-
um (DMEM) supplemented with 10% heat-inactivated
FBS.
Plasmids
The full-length ORF57 was amplified from BCBL-1 total
RNA by RT-PCR using the primers ORF57FP (5V-AAG
GAT CCA GGC CAT GGT ACA AGC AAT GAT AGA C-
3V) and ORF57RP (5V-AAG GAT CCA AGA AAG TGG
ATA AAA GAA TAA AC-3V). The amplified DNA frag-
ment was digested with BamHI and inserted into the BglII
site of the pCMV-HA expression vector (Clontech) or the
BamHI site of the pEBV-HisC expression vector (Invitro-
gen), and these constructs were named pCMV-HA-ORF57
and pEBV-HisC-ORF57, respectively.
The ORF57 cDNA sequence was excised from pEBV-
His-ORF57 using BamHI and subcloned into the BamHI
site of the pBD-Gal4-Cam plasmid (Clontech). The resultant
plasmid, named pBD-ORF57, was used in the yeast two-
hybrid screen as bait.
The N-terminal region of ORF57 (aa 1–389) was gel
purified by digesting pEBV-HisC-ORF57 with BamHI and
HindIII, and inserted into the BamHI and HindIII sites of
pGEX-5X-2 (Amersham Bioscience). This plasmid, named
pGEX-ORF57-1167, was used to produce antigen in E. coli
to make anti-ORF57 antibodies.
Truncated cDNA fragments of ORF57 (DC205, DC104,
DN179, and 178–205, schematically shown in Fig. 4A) were
amplified by PCR with primers ORF57p1-Bam (5V-CGC
GGA TCC GAA TGG TAC AAG CAA TGA TAG ACA-
3V) and ORF57rp3-stopBam (5V-CGC GGA TCC TTA ATT
GAA ACA TGC GCC ATG GTG-3V) for ORF57DC205,
ORF57p1-Bam and ORF57rp2-stopBam (5V-CGC GGA
TCC TTA ACC GTA CCT GTT TAC TGG TGA-3V) for
ORF57DC104, ORF57p2-Bam (5V-CGC GGA TCC GAC
CTG CGA GCA TGA TAA TTG ACG-3’) and ORF57rp5-
Bam (5V-CGC GGATCC TTA AGA AAG TGG ATA AAA
GAA TAA-3V) for ORF57DN179, and ORF57p2-Bam and
ORF57rp3-stopBam for ORF57[179–205]. These fragments
were individually inserted into pCMV-HA at the BglII site.
The PCBP1 cDNA fragment corresponding to aa 48–
356 was excised with XhoI from pACT-#73, the plasmid
isolated from yeast two-hybrid screening, and inserted into
the XhoI site of pGEX-5X-2. A recombinant GST-fused
PCBP1 protein produced in E. coli from the resultant
plasmid, pGEX-PCBP1DN, was used for the GST pull-
down assay.
The full-length PCBP1 cDNAwas amplified from 293 cell
total RNA by RT-PCR using the primers PCBP1p1-Eco (5V-CGG AAT TCC ATG GAT GCC GGT GTG ACT GAA-3V)
and PCBP1rp1-Eco (5V-CGG AAT TCC CTA GCT GCA
CCC CAT GCC CTT-3V). The amplified DNA fragment was
digested with EcoRI and ligated into the pFLAG-CMV-2
expression vector (Sigma), and the construct was named
pFLAG-PCBP1.
Truncated cDNA fragments of PCBP1 (DC279, DC169,
DC96, and DN97, schematically shown in Fig. 5A) were
amplified by PCR with primers PCBP1p5-Eco (5V-CGG
AAT TCC AAC ATC TCG GAG GGG AAT TGT-3V) and
PCBP1rp3-stopEco (5V-CGG AAT TCC TTA AGT AGA
TGC ATC CAA ACT-3V) for PCBP1DC279, PCBP1p5-Eco
and PCBP1rp4-stopEco (5V-CGG AAT TCC TTA GTC
TCC AGC ATG ACC AGG-3V) for PCBP1DC169,
PCBP1p5-Eco and PCBP1rp5-stopEco (5V-CGG AAT
TCC TTA GGG CCT GCT GGC CGC GGT-3V) for
PCBP1DC96, and PCBP1p6-Eco (5V-CGG AAT TCC
CCG GTC ACC CTG AGG CTG GTG-3 V) and
PCBP1rp1-Eco for PCBP1DN97. These fragments were
individually inserted into pGEX-5X-3 at the EcoRI site.
The bicistronic h-galactosidase/luciferase reporter con-
structs, pCMVh-IRES-Luc, were based on pCMVh (Clon-
tech) and pGL3-Basic (Promega). The poliovirus internal
ribosome-entry site (IRES) sequence was excised from the
construct pBKS-IRES (kindly provided by Dr. Nomoto,
University of Tokyo, Tokyo, Japan) using SacI and SalI,
and subcloned into the SacI-XhoI site, just upstream of the
luciferase gene in pGL3-Basic. The resultant construct,
pGL3-IRES, was digested with NotI and SalI, and the
DNA fragment containing the IRES sequence followed by
the luciferase gene was blunted and ligated into the blunted
BsmI site just downstream of the h-galactosidase gene of
pCMVh. The poliovirus IRES sequence in the pCMVh-
IRES-Luc bicistronic reporter plasmid was removed by
BglII digestion to create the IRES-minus construct,
pCMVh-con-Luc, which was used as a control vector. The
IRES sequences of c-myc, NRF, XIAP, and vFLIP were
amplified by PCR using the primers: myc IRES p1-Bgl (5V-
GAA AGATCT AAC TCG CTG TAG TAA TTC CAG-3V)
and myc IRES rp1-Bgl (5V-GAA AGA TCT CGT CTA
AGC AGC TGC AAG GAG-3V) (for c-myc IRES), NRF
IRES p1-Bgl (5V-GAA AGA TCT CAG AGT AAT GAC
ATG GTT CCT-3V) and NRF IRES rp1-Bgl (5V-GAA AGA
TCT CAA GCG TGG GCT GTA CCT ATT-3V) (for NRF
IRES), XIAP IRES p1-Bgl (5V-GAA AGA TCT AAT TAG
AAT GTT TCT TAG CGG-3V) and XIAP IRES rp1-Bgl (5V-
GAA AGA TCT CTT CTC TGG AAA ATA GGA C-3V)
(for XIAP IRES), and vFLIP IRES p2-Bgl (5V-GAA AGA
TCT GGT GCC GGC TTG TAT ATG TGA-3V) and vFLIP
IRES rp1-Bgl (5V-GAA AGA TCT CCG CGG CAG ACT
CCT TTT CCC-3V) (for vFLIP IRES). The amplified DNA
fragments were digested with BglII and inserted into the
BglII site of pCMVh-con-Luc.
The full-length ORF of XIAP was amplified with a
reverse transcriptase (Superscript II, Invitrogen) and then
pfu polymerase (Promega) with XIAP-S (5V-AAG GAT
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AS (5V-AAC TCG AGA GAC ATA AAA ATT TTT TGC
TTG-3V) as primers and substrates. The amplified XIAP
ORF fragment was inserted into the BamHI and XhoI sites
of the pQE-TriSystem His-Strep2 vector (Qiagen) and
termed pQE-TriSystem His-Strep2 XIAP.
A part of GAPDH cDNA was also amplified with
GAPDH-FW (5 V-CCT TCA TTG ACC TCA ACT ACA
TGG T-3V) and GAPDH-RV (5V-CCT TCT CCATGG TGG
TGA AGA CGC C-3V) and cloned into pbluescript II
(Strategene), termed pBS-GAPDH.
All the DNA fragments generated by PCR were se-
quenced and confirmed with an ABI PRISM 310 Genetic
Analyzer (Perkin-Elmer).
Production and affinity purification of mouse anti-ORF57
antibodies
BALB/c mice were immunized with a purified GST
fusion protein, GST-ORF57-1167, produced in E. coli
(OrigamiB (DE3); Novagen), and transformed with the
pGEX-ORF57-1167, as described previously (Okuno et
al., 1990). Immunizations were carried out three times with
100 Ag GST-ORF57-1167 in complete Freund’s adjuvant at
3- to 4-week intervals.
Hybridomas were established by fusing splenocytes from
hyperimmune mice with the nonproducing myeloma cell
line Sp2/0-Ag14. After selection in medium containing
hypoxanthine/aminopterin/thymidine, cells secreting mAbs
were screened by indirect IFA. The clones secreting anti-
bodies that reacted with 293 cells transfected with pCMV-
ORF57 and TPA-induced BCBL-1 cells were expanded and
cloned by limiting dilutions. Finally, we established three
kinds of hybridomas producing monoclonal antibodies
against ORF57. One, called K1, was purified by Protein
A-Sepharose (Amersham Bioscience) from serum-free cul-
ture supernatant.
Immunofluorescence assay (IFA)
BCBL-1 cells were untreated or treated with TPA. At the
selected time postinduction, the cells were harvested,
washed twice with PBS, spotted onto glass slides, air-dried,
and fixed with acetone/methanol (50:50) for 10 min at 20
jC. The fixed cells were incubated for >12 h at room
temperature with the mouse monoclonal antibody (diluted
to 1.0 Ag/ml) against ORF57. After washing three times
with PBS containing 0.05% Tween 20 for 5 min each, the
slides were air-dried and incubated with appropriately
diluted (1:100) fluorescein isothiocyanate (FITC)-conjugat-
ed goat anti-mouse IgG antibodies (DAKO) for 1 h,
followed by DAPI for another 5 min. In the case of 293
cells transfected with pFLAG-PCBP1 and pCMV-HA-
ORF57, the transfected cells were transferred to an eight-
chamber glass slide 24 h after transfection and fixed 48
h after transfection. The fixed cells were labeled with ananti-FLAG mouse monoclonal antibody (Sigma) (1:1000
dilution) and anti-HA rabbit polyclonal antibodies (Clon-
tech) (1:20 dilution), followed by FITC-conjugated goat
anti-mouse IgG antibodies and tetramethylrhodamine iso-
thiocyanate (TRITC)-conjugated swine anti-rabbit IgG anti-
bodies (DAKO). After washing the slides as described
above, the cells were mounted with 90% glycerol in PBS
and the signals were detected with a confocal fluorescence
microscope, LSM 510 (Zeiss).
Western blotting
Whole-cell protein extract was prepared in RIPA buffer
and nuclear protein extract was prepared using a CelLytic
NuCLEAR Extraction Kit (Sigma) according to the manu-
facturer’s instructions. The protein concentration of the
extracts was determined by Bradford assay. Samples were
subjected to sodium dodecyl sulfate-10% polyacrylamide
gel electrophoresis (SDS-PAGE) under reducing conditions,
then electrophoretically transferred to polyvinylidene
difluoride membranes (Bio-Rad) in 25 mM ethanolamine/
NaOH (pH 9.5). The membranes were blocked for 1 h with
shaking at room temperature in TBS (137 mM NaCl, 2.68
mM KCl, 25 mM Tris) containing 0.05% Tween 20 and 5%
dry milk, then incubated with the specific antibodies for
ORF57 (diluted to 0.1 Ag/ml in TBS-0.05% Tween 20),
RTA, XIAP (BD Biosciences), or tubulin (Sigma) for 1
h with shaking at room temperature. After being washed
three times for 5 min each in TBS-0.05% Tween 20, the
membrane was incubated for 1 h at room temperature with
horseradish peroxidase-conjugated donkey anti-mouse IgG
antibodies (1:5000 dilution) (Amersham Bioscience). The
signal was detected using Super Signal West Pico Chemi-
luminescent substrate (PIERCE) according to the manufac-
turer’s instructions. The band intensity was quantified using
a GS-800 Calibrated Densitometer (Bio-Rad).
Yeast two-hybrid screen
pBD-ORF57, which expressed full-length ORF57 fused
to the Gal4 DNA binding domain, was used as bait to screen
a cDNA library from EBV-transformed B cells (Clontech).
The yeast reporter strain HF7C was transformed simulta-
neously with pBD-ORF57 and about 1  106 independent
cDNA clones in pACT (Clontech). His+ colonies were then
tested for h-galactosidase activity with a filter lift assay.
Plasmids were retrieved from the His+ and LacZ+ colonies
and isolated in E. coli DH5a with ampicillin resistance. The
DNA and protein sequence analyses and homology searches
were performed using the BLAST program (NCBI).
GST pull-down assay
OrigamiB (DE3) pLacI (Novagen) E. coli was trans-
formed either with pGEX-5X-2 or plasmids encoding GST-
fusion truncated PCBP1 (PCBP1DN, DC279, DC169,
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mM IPTG. Extract from the induced E. coli was treated with
25 mU/ml Benzonase nuclease (Novagen) for 15 min at 37
jC and then incubated in 100 Al packed glutathione-Sephar-
ose 4B beads (Amersham Bioscience) and agitated for 1 h on
a rotary mixer at room temperature, followed by three
washes with PBS. Nuclear extract from TPA-induced BC-
3 cells or whole-cell protein extracts from 293 cells trans-
fected with pCMV-HA-ORF57, pCMV-HA-ORF57DC104,
pCMV-HA-ORF57DC205, pCMV-HA-ORF57DN179, or
pCMV-HA-ORF57(178–205) were added to the GST- or
GST-fusion truncated PCBP1-bound beads and incubated at
4 jC overnight with rotation. The beads were washed five
times with PBS and boiled in SDS-PAGE sample buffer.
The unbound flow-through and the eluted glutathione-
bound fractions were then subjected to SDS-PAGE, fol-
lowed by immunoblotting.
Immunoprecipitation of ORF57–PCBP1 complex
Nuclear extracts from 293 cells transfected with 0.1 Ag of
pFLAG-PCBP1 (or pFLAG-CMV-2 as a control) and 2.0 Ag
pCMV-HA-ORF57 (or pCMV-HA as a control) were pre-
pared, and the extracts were incubated with anti-HA rabbit
polyclonal antibodies (Sigma) in 50 mM Tris–HCl (pH 8.0)
containing 150 mM NaCl and protease inhibitors at 4 jC
overnight with rotation. The protein–antibody complexes
were recovered with Protein G-Sepharose (Amersham),
washed four times with 50 mM Tris–HCl (pH 8.0), and
resuspended in SDS-PAGE sampling buffer. The samples
were analyzed by Western blotting with the mouse monoclo-
nal antibody against FLAG-tag or ORF57 mentioned above.
Transfection and luciferase and b-galactosidase assays
293 cells were plated onto 6-well dishes 1 day before
transfection and grown to 70–80% confluence. The cells
were transfected with 0.1 Ag of reporter plasmid (pCMVh-
IRES-Luc), either 0.1 Ag of pFLAG-PCBP1 or pFLAG-
CMV-2 (control), and 2.0 Ag pCMV-HA-ORF57, pCMV-
HA-ORF57DC104, or pCMV-HA (control) using SuperFect
(QIAGEN) according to the manufacturer’s protocol. Thir-
ty-six hours after transfection, the cell extract was prepared
and used for activity assays. Luciferase activity was deter-
mined using the luciferase assay system (Promega) and h-
galactosidase activity using the h-galactosidase enzyme
assay system (Clontech). The relative luciferase activity
was calculated by normalizing the luciferase activity to the
h-galactosidase activity. Each assay was done in triplicate in
at least two independent experiments. A reporter plasmid
lacking the poliovirus IRES sequence was also tested to
determine the efficacy of IRES in expressing the luciferase
gene. In this case, 0.1 Ag of each reporter construct,
pCMVh-IRES-Luc or pCMVh-Luc, was transfected into
293 cells and the luciferase activity was measured as
described above.Real-time PCR
293 cells were transfected with 0.1 Ag of the reporter
construct, pCMVh-IRES-Luc, with 0.1 Ag of either pFLAG-
PCBP1 or pFLAG-CMV-2, and 2.0 Ag pCMV-HA-ORF57,
pCMV-HA-ORF57DC104, or pCMV-HA, as above. Thirty-
six hours after transfection, the cells were harvested and
total RNA was extracted using the WizardR SV RNA
ISOLATION SYSTEM (Promega) according to the manu-
facturer’s instructions. Approximately 10 Ag of the RNA
was subjected to cDNA synthesis with a reverse transcrip-
tase (SuperscriptR III, Invitrogen) and substrates. The
synthesized cDNA was suspended in 20 Al of H2O, and 1
Al of each sample was used for real-time PCR using the LC
FAST START DNA MASTER Sybr Green kit (Roche
Diagnostics) and LightR Cycler (Roche Diagnostics). Pri-
mers used in the reaction were: LacZ-FW (5V-CCA TGT
CGT TTA CTT TGA CCA AC-3V) and LacZ-RV2 (5V-TCG
TAA CCG TGC ATC TGC CAG TTT GA-3V) for the h-
galactosidase gene, LuciPCR-FW (5V-ACC ATG GAA
GAC GCC AAA AAC ATA AAG-3V) and LuciPCR-RV
(5V-AGC AAT TCA CGT TCATTATAA ATG TCG-3V) for
luciferase, XIAP-FW (5V-GGT GAT AAA GTA AAG TGC
TTT CAC TGT-3V) and XIAP-RV for XIAP, ORF57-5VI (5V-
AAG GAT CCG GAT GAC GAC GTC AGA CAG GGT
GTG-3V) and ORF57 R1 (5V-ACG CTT GAT TAT GGC
GGC TGG TC-3V) for ORF57, ORF50S2 (5V-AAA TGG
CGC AAG ATG ACA AG-3V) and ORF50AS (5V-AGG
CTC ACC CCG CTG CAT GCG GC-3V) for the ORF50
gene, and GAPDH-FW (5V-CCT TCATTG ACC TCA ACT
ACATGG T-3V) and GAPDH-RV (5V-CCT TCT CCATGG
TGG TGA AGA CGC C-3V) for GAPDH, respectively.
Copy number was estimated by comparing the results to
those obtained with standard plasmids: pCMVh (Clontech)
for the h-galactosidase gene, pQE-TriSystem His-Strep2
XIAP for the XIAP gene, pG5luc (Promega) for the lucif-
erase gene, pcDNA3.1-ORF50 (Chen et al., 2000) for the
RTA gene, pCMV-HA-ORF57 for the ORF57 gene, and
pBS-GAPDH for GAPDH, respectively. To calculate the
RNA level of the luciferase gene, the transfection efficiency
was normalized using the h-galactosidase copy number.
Triplicate transfections were performed in two separate
experiments, and the mean and standard deviation was
calculated. The RNA expression level of the respective
XIAP, RTA, and ORF57 genes was normalized to the
GAPDH copy number, and the RNA level in the presence
of Tc was set at 1 in the BCBL-1/off + RTA cells.
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